Filing Details
- Accession Number:
- 0001161697-22-000553
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-17 17:00:31
- Reporting Period:
- 2022-11-15
- Accepted Time:
- 2022-11-17 17:00:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1402652 | Alicia Grande | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Vp, Treasurer And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Disposition | 2022-11-15 | 60,000 | $15.77 | 147,442 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Ms. Grande remains an officer of the Company.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.76 to $15.795 per share.